One-year safety and effectiveness of the Agent paclitaxel-coated balloon for the treatment of small vessel disease and in-stent restenosis.
Drug-coated balloon
In-stent restenosis
Small vessel disease
Journal
Cardiovascular intervention and therapeutics
ISSN: 1868-4297
Titre abrégé: Cardiovasc Interv Ther
Pays: Japan
ID NLM: 101522043
Informations de publication
Date de publication:
29 Aug 2023
29 Aug 2023
Historique:
received:
05
06
2023
accepted:
17
08
2023
medline:
29
8
2023
pubmed:
29
8
2023
entrez:
29
8
2023
Statut:
aheadofprint
Résumé
The Agent device consists of a semi-compliant balloon catheter, which is coated with a therapeutic low-dose formulation of paclitaxel (2 µg/mm
Identifiants
pubmed: 37642826
doi: 10.1007/s12928-023-00953-8
pii: 10.1007/s12928-023-00953-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Tian J, da Tang Y, Qiao S, et al. Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: the RESTORE Small Vessel Disease China trial. Catheter Cardiovasc Interv. 2020;95(Suppl 1):587–97. https://doi.org/10.1002/ccd.28705 . (Epub 2020 Jan 13).
doi: 10.1002/ccd.28705
pubmed: 31943693
Jeger RV, Farah A, Ohlow MA, et al. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet. 2018;392(10150):849–56. https://doi.org/10.1016/S0140-6736(18)31719-7 . (Epub 2018 Aug 28).
doi: 10.1016/S0140-6736(18)31719-7
pubmed: 30170854
Kleber FX, Mathey DG, Rittger H, Scheller B, German Drug-eluting Balloon Consensus Group. How to use the drug-eluting balloon: recommendations by the German consensus group. EuroIntervention. 2011;7(Suppl K):K125–8. https://doi.org/10.4244/EIJV7SKA21 .
doi: 10.4244/EIJV7SKA21
pubmed: 22027722
Her A-Y, Shin E-S, Bang LH, et al. Drug-coated balloon treatment in coronary artery disease: Recommendations from an Asia-Pacific Consensus Group. Cardiol J. 2021;28(1):136–49. https://doi.org/10.5603/CJ.a2019.0093 . (Epub 2019 Sep 30).
doi: 10.5603/CJ.a2019.0093
pubmed: 31565793
pmcid: 8105061
Jeger RV, Eccleshall S, Wan Ahmad WA, et al. Drug-coated balloons for coronary artery disease: third report of the International DCB Consensus Group. JACC Cardiovasc Interv. 2020;13(12):1391–402. https://doi.org/10.1016/j.jcin.2020.02.043 . (Epub 2020 May 27).
doi: 10.1016/j.jcin.2020.02.043
pubmed: 32473887
De Labriolle A, Pakala R, Bonello L, Lemesle G, Scheinowitz M, Waksman R. Paclitaxel-eluting balloon: from bench to bed. Catheter Cardiovasc Interv. 2009;73(5):643–52. https://doi.org/10.1002/ccd.21895 .
doi: 10.1002/ccd.21895
pubmed: 19309715
Cortese B, Bertoletti A. Paclitaxel coated balloons for coronary artery interventions: a comprehensive review of preclinical and clinical data. Int J Cardiol. 2012;161(1):4–12. https://doi.org/10.1016/j.ijcard.2011.08.855 .
doi: 10.1016/j.ijcard.2011.08.855
pubmed: 21955612
Gutiérrez-Chico JL, van Geuns RJ, Koch KT, Koolen JJ, Duckers H, Regar E, Serruys PW. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. EuroIntervention. 2011;7(6):711–22. https://doi.org/10.4244/EIJV7I6A114 .
doi: 10.4244/EIJV7I6A114
pubmed: 21986329
Belkacemi A, Agostoni P, Voskuil M, Stella PR. Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study. EuroIntervention. 2011;7:K66–9. https://doi.org/10.4244/EIJV7SKA12 .
doi: 10.4244/EIJV7SKA12
pubmed: 22027731
Ahmed W, Shah MA, Thaver AM, Mirza J. Drug-eluting balloon (DEB) for de-novo coronary artery disease and in-stent restenosis: immediate and intermediate term results from a prospective registry. J Pak Med Assoc. 2011;61(2):157–60.
pubmed: 21375166
Ali RM, Degenhardt R, Zambahari R, Tresukosol D, Ahmad WAW, Kamar HBH, Kui-Hian S, Ong TK, bin Ismail O, bin Elis S, Udychalerm W, Ackermann H, Boxberger M, Unverdorben M. Paclitaxel-eluting balloon angioplasty and cobalt chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention. 2011;7(Suppl K):K83–92. https://doi.org/10.4244/EIJV7SKA15 .
doi: 10.4244/EIJV7SKA15
pubmed: 22027736
Loh JP, Waksman R. Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions. JACC Cardiovasc Interv. 2012;5(10):1001–12. https://doi.org/10.1016/j.jcin.2012.08.005 .
doi: 10.1016/j.jcin.2012.08.005
pubmed: 23078727
Bonaventura K, Sonntag S, Kleber FX. Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons. EuroIntervention. 2011;7(Suppl K):K106–11. https://doi.org/10.4244/EIJV7SKA18 .
doi: 10.4244/EIJV7SKA18
pubmed: 22027718
Nakamura M, et al. Drug-coated balloon for the treatment of small vessel coronary artery disease—a randomized non-inferiority trial. Circ J. 2023;87(2):287–95. https://doi.org/10.1253/circj.CJ-22-0584 . (Epub 2022 Dec 1).
doi: 10.1253/circj.CJ-22-0584
pubmed: 36450540
Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344–51. https://doi.org/10.1161/CIRCULATIONAHA.106.685313 .
doi: 10.1161/CIRCULATIONAHA.106.685313
pubmed: 17470709
Siontis GCM, Stefanini GG, Mavridis D, et al. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. Lancet. 2015;386(9994):655–64. https://doi.org/10.1016/S0140-6736(15)60657-2 .
doi: 10.1016/S0140-6736(15)60657-2
pubmed: 26334160
Yeh RW, Bachinsky W, Stoler R, Bateman C, Tremmel JA, Abbott JD, et al. Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with in-stent restenosis. Am Heart J. 2021;241:101–7. https://doi.org/10.1016/j.ahj.2021.07.008 . (Epub 2021 Jul 24).
doi: 10.1016/j.ahj.2021.07.008
pubmed: 34314727
Cortese B, Di Palma G, Guimaraes MG, Piraino D, Orrego PS, Buccheri D, et al. Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial. JACC Cardiovasc Interv. 2020;13(24):2840–9. https://doi.org/10.1016/j.jcin.2020.08.035 . (Epub 2020 Nov 25).
doi: 10.1016/j.jcin.2020.08.035
pubmed: 33248978
Jeger RV, Farah A, Ohlow MA, Mangner N, Möbius-Winkler S, Leibundgut G, et al. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomized non-inferiority trial. Lancet. 2018;392(10150):849–56. https://doi.org/10.1016/S0140-6736(18)31719-7 . (Epub 2018 Aug 28).
doi: 10.1016/S0140-6736(18)31719-7
pubmed: 30170854
Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study. J Am Coll Cardiol. 2012;60(24):2473–80. https://doi.org/10.1016/j.jacc.2012.09.020 . (Epub 2012 Nov 14).
doi: 10.1016/j.jacc.2012.09.020
pubmed: 23158530
Naganuma T, Latib A, Sgueglia GA, et al. A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study. Int J Cardiol. 2015;1(184):17–21. https://doi.org/10.1016/j.ijcard.2015.01.080 . (Epub 2015 Jan 29).
doi: 10.1016/j.ijcard.2015.01.080
Tang Y, Qiao S, Su X, Chen Y, Jin Z, Chen H, et al. Drug-coated balloon versus drug-eluting stent for small-vessel disease: the RESTORE SVD China randomized trial. JACC Cardiovasc Interv. 2018;11(23):2381–92. https://doi.org/10.1016/j.jcin.2018.09.009 .
doi: 10.1016/j.jcin.2018.09.009
pubmed: 30522667
Sebastian K, Himanshu R, Jens W, Felix A, Stylianos P, Michael J, et al. A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents intracoronary stenting and angiographic results: optimizing treatment of drug eluting stent in-stent REstenosis 3A (ISAR-DESIRE 3A). Catheter Cardiovasc Interv. 2022;99(3):754–62. https://doi.org/10.1002/ccd.30014 . (Epub 2021 Nov 18).
doi: 10.1002/ccd.30014
Alexander K. Quality of life after coronary artery bypass graft surgery versus percutaneous coronary intervention what do the trials tell us? Curr Opin Cardiol. 2017;32(6):707–14. https://doi.org/10.1097/HCO.0000000000000458 .
doi: 10.1097/HCO.0000000000000458
Felix M, Ahmed F, Marc-Alexander O, Norman M, Jochen W, et al. Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specifed analysis of the BASKET-SMALL 2 trial. Clin Res Cardiol. 2022;111(7):806–15. https://doi.org/10.1007/s00392-022-01995-3 . (Epub 2022 Feb 27).
doi: 10.1007/s00392-022-01995-3